Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
Search by condition
Search By:
30 results
  • Lung Cancer, Colorectal Cancer, Ovarian Cancer, Melanoma, Breast Cancer

20-079          Phase I

A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies (View details on clinicaltrial.gov)

  • Lung Cancer, Colorectal Cancer

20-177          Phase I

A First-in-Human, Phase 1a/1b, Open-Label, Dose-Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, and Antitumor Activity of the RAF Dimer Inhibitor BGB-3245 in Patients with Advanced or Refractory Tumors (View details on clinicaltrial.gov)

  • Ovarian Cancer, Lung Cancer, Colorectal Cancer, Breast Cancer

20-211          Phase I

A Phase 1 Study of SY-5609, an Oral, Selective CDK7 Inhibitor, in Adult Patients With Select Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Lung Cancer, Melanoma, Colorectal Cancer, Pancreatic Cancer

21-184          Phase I

A Phase 1, First-in-Human Study of DCC-3116 as a Single Agent and in Combination with Trametinib in Patients with Advanced or Metastatic Solid Tumors with RAS or RAF Mutations (View details on clinicaltrial.gov)

  • Lung Cancer, Breast Cancer, Endometrial Cancer, Colorectal Cancer, Ovarian Cancer

20-444          Phase I

A Phase 1, First-in-human Study of the Safety, Single- and Multiple-Dose Pharmacokinetics, and Preliminary Activity of Escalating Doses of RBN-2397, an Oral PARP7 Inhibitor, in Patients with Solid Tumors (View details on clinicaltrial.gov)

  • Colorectal Cancer, Ovarian Cancer, Breast Cancer, Esophageal Cancer, Lung Cancer, Gastric (Stomach) Cancer

22-235          Phase I

A Phase 1, Open-Label, Multicenter, Dose Escalation Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of IMM2902 in Patients with HER2-Expressing Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Ovarian Cancer, Lung Cancer, Endometrial Cancer, Colorectal Cancer

21-060          Phase II

A Phase 1/2 Study Evaluating the Safety, Tolerability and Preliminary Antitumor Activity of COM701 in Combination with BMS-986207 (anti-TIGIT antibody) and Nivolumab in Subjects with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Prostate Cancer, Lung Cancer, Colorectal Cancer, Ovarian Cancer, Breast Cancer, Melanoma

22-577          Phase II

A Phase 1/2, First-in-Human, Open-Label, Dose Escalation and Expansion Study of STAR0602, a Selective T Cell Receptor (TCR)-targeting, Bifunctional Antibody-fusion Molecule, in Subjects with Unresectable, Locally Advanced, or Metastatic Solid Tumors that are Antigen-rich (START-001) (View details on clinicaltrial.gov)

  • Colorectal Cancer, Lung Cancer, Melanoma, Pancreatic Cancer

22-595          Phase II

A Phase 1/2A Open-label, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Mirdametinib in Combination with BGB-3245 in Patients with Advanced Solid Tumors (View details on clinicaltrial.gov)

Showing 1 - 10 of 30 results